Page last updated: 2024-08-24

fluorodeoxyglucose f18 and msdc-0160

fluorodeoxyglucose f18 has been researched along with msdc-0160 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrews, RD; Capuano, AW; Colca, JR; Fleischman, DA; Matthews, DC; Shah, RC; VanderLugt, JT	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and msdc-0160

Article	Year
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease. Current Alzheimer research, 2014, Volume: 11, Issue:6 Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Central Nervous System Agents; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome	2014

Article

Year

An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.

Current Alzheimer research, 2014, Volume: 11, Issue:6

Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Central Nervous System Agents; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome

2014